Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$53.43 - $68.12 $1.49 Million - $1.89 Million
-27,799 Reduced 38.56%
44,300 $2.74 Million
Q4 2022

Feb 14, 2023

SELL
$61.23 - $83.62 $175 Million - $238 Million
-2,851,963 Reduced 97.53%
72,099 $4.58 Million
Q3 2022

Nov 14, 2022

BUY
$65.58 - $84.69 $327,768 - $423,280
4,998 Added 0.17%
2,924,062 $212 Million
Q2 2022

Aug 15, 2022

BUY
$52.13 - $93.81 $4.22 Million - $7.6 Million
81,019 Added 2.85%
2,919,064 $198 Million
Q1 2022

May 16, 2022

BUY
$64.92 - $99.47 $1.44 Million - $2.2 Million
22,159 Added 0.79%
2,838,045 $257 Million
Q4 2021

Feb 14, 2022

BUY
$76.51 - $93.96 $25.9 Million - $31.8 Million
338,948 Added 13.68%
2,815,886 $257 Million
Q3 2021

Nov 15, 2021

BUY
$71.29 - $95.99 $140 Million - $189 Million
1,964,888 Added 383.73%
2,476,938 $201 Million
Q2 2021

Aug 16, 2021

BUY
$79.62 - $114.85 $4.94 Million - $7.13 Million
62,050 Added 13.79%
512,050 $47.8 Million
Q2 2020

Aug 14, 2020

BUY
$42.51 - $52.46 $19.1 Million - $23.6 Million
450,000 New
450,000 $21.8 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.